T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Mattel
MAT
$4.19B
| $173M | 0.02% |
15,468,714
-294,853
| -2% | -$3.46M |
|
502
LivaNova
LIVN
$4.45B
| $172M | 0.02% |
2,395,068
+378,564
| +19% | +$27.7M |
|
503
Ralph Lauren
RL
$23.6B
| $172M | 0.02% |
1,510,879
+108,474
| +8% | +$13M |
|
|
APC
504
DELISTED
Anadarko Petroleum
APC
| $171M | 0.02% |
2,425,544
+1,499,195
| +162% | +$101M |
|
505
Westamerica Bancorp
WABC
$1.38B
| $170M | 0.02% |
2,752,752
+114,439
| +4% | +$7.12M |
|
506
Performance Food Group
PFGC
$16.9B
| $166M | 0.02% |
4,134,547
-67,688
| -2% | -$2.71M |
|
507
Prosperity Bancshares
PB
$8.95B
| $165M | 0.02% |
2,504,790
-20,979
| -0.8% | -$1.45M |
|
508
Lockheed Martin
LMT
$140B
| $165M | 0.02% |
454,920
+1,698
| +0.4% | +$568K |
|
509
Steris
STE
$23.1B
| $165M | 0.02% |
1,108,078
-4,581
| -0.4% | -$612K |
|
510
Kemper
KMPR
$1.56B
| $165M | 0.02% |
1,907,807
+19,850
| +1% | +$1.7M |
|
511
PagerDuty
PD
$876M
| $164M | 0.02% |
+3,642,881
| New | +$177M |
|
|
AMED
512
DELISTED
Amedisys
AMED
| $164M | 0.02% |
1,349,405
+999,892
| +286% | +$119M |
|
513
Jacobs Solutions
J
$17B
| $162M | 0.02% |
2,314,982
+1,484,671
| +179% | +$95.8M |
|
514
KeyCorp
KEY
$24.5B
| $161M | 0.02% |
9,045,373
-3,185,851
| -26% | -$53.9M |
|
515
Vornado Realty Trust
VNO
$7.33B
| $160M | 0.02% |
2,493,580
-887,345
| -26% | -$59.7M |
|
516
Sysco
SYY
$40.5B
| $158M | 0.02% |
2,227,503
+24,707
| +1% | +$1.76M |
|
517
Sunstone Hotel Investors
SHO
$2.01B
| $157M | 0.02% |
11,456,786
-885,191
| -7% | -$12.5M |
|
518
Popular Inc
BPOP
$11.2B
| $156M | 0.02% |
2,877,066
-120,944
| -4% | -$6.61M |
|
519
Columbia Banking Systems
COLB
$9.12B
| $156M | 0.02% |
4,301,678
-26,498
| -0.6% | -$938K |
|
|
GWR
520
DELISTED
Genesee & Wyoming Inc.
GWR
| $155M | 0.02% |
1,554,459
-12,695
| -0.8% | -$1.16M |
|
521
The Ensign Group
ENSG
$10.6B
| $155M | 0.02% |
2,918,627
-34,555
| -1% | -$1.73M |
|
|
XLRN
522
DELISTED
Acceleron Pharma
XLRN
| $155M | 0.02% |
3,774,113
-721,300
| -16% | -$29.9M |
|
|
TCDA
523
DELISTED
Tricida, Inc. Common Stock
TCDA
| $154M | 0.02% |
3,901,325
+1,603,231
| +70% | +$56.4M |
|
524
Caterpillar
CAT
$393B
| $154M | 0.02% |
1,128,036
-479,989
| -30% | -$63.4M |
|
|
DENN
525
DELISTED
Denny's
DENN
| $153M | 0.02% |
7,447,264
-1,208,678
| -14% | -$23.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.